184 related articles for article (PubMed ID: 37919464)
21. Ganoderma lucidum Polysaccharide Peptide Attenuates Skin Flap Ischemia-Reperfusion Injury in a Thioredoxin-Dependent Manner.
Ren H; Meng X; Yin J; Sun J; Huang Q; Yin Z
Plast Reconstr Surg; 2018 Jul; 142(1):23e-33e. PubMed ID: 29649063
[TBL] [Abstract][Full Text] [Related]
22. Anticancer and Anti-Inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment.
Barbieri A; Quagliariello V; Del Vecchio V; Falco M; Luciano A; Amruthraj NJ; Nasti G; Ottaiano A; Berretta M; Iaffaioli RV; Arra C
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264501
[TBL] [Abstract][Full Text] [Related]
23. Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3.
Hsieh TC; Wu JM
Int J Mol Med; 2011 Dec; 28(6):1065-9. PubMed ID: 21887458
[TBL] [Abstract][Full Text] [Related]
24. Polysaccharide from spore of Ganoderma lucidum ameliorates paclitaxel-induced intestinal barrier injury: Apoptosis inhibition by reversing microtubule polymerization.
Li D; Gao L; Li M; Luo Y; Xie Y; Luo T; Su L; Yong T; Chen S; Jiao C; Su J; Huang S
Biomed Pharmacother; 2020 Oct; 130():110539. PubMed ID: 32768880
[TBL] [Abstract][Full Text] [Related]
25. Sporoderm-Removed
Liu G; Zeng T
Integr Cancer Ther; 2021; 20():15347354211062157. PubMed ID: 34841952
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic and Proapoptotic Activities of Atorvastatin and Ganoderma lucidum in Tumor Mouse Model via VEGF and Caspase-3 Pathways.
El-Khashab IH
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1095-1104. PubMed ID: 33906301
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of enzymatically hydrolyzed
Kong M; Yao Y; Zhang H
Int J Immunopathol Pharmacol; 2019; 33():2058738419869489. PubMed ID: 31462112
[TBL] [Abstract][Full Text] [Related]
28. Synergistic anti-tumor effects of Liraglutide, a glucagon-like peptide-1 receptor agonist, along with Docetaxel on LNCaP prostate cancer cell line.
Eftekhari S; Montazeri H; Tarighi P
Eur J Pharmacol; 2020 Jul; 878():173102. PubMed ID: 32283060
[TBL] [Abstract][Full Text] [Related]
29. Ganoderma lucidum polysaccharide reduces melanogenesis by inhibiting the paracrine effects of keratinocytes and fibroblasts via IL-6/STAT3/FGF2 pathway.
Jiang L; Huang J; Lu J; Hu S; Pei S; Ouyang Y; Ding Y; Hu Y; Kang L; Huang L; Xiang H; Zeng Q; Liu L; Chen J; Zeng Q
J Cell Physiol; 2019 Dec; 234(12):22799-22808. PubMed ID: 31115052
[TBL] [Abstract][Full Text] [Related]
30. Coprinus comatus and Ganoderma lucidum interfere with androgen receptor function in LNCaP prostate cancer cells.
Zaidman BZ; Wasser SP; Nevo E; Mahajna J
Mol Biol Rep; 2008 Jun; 35(2):107-17. PubMed ID: 17431821
[TBL] [Abstract][Full Text] [Related]
31. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells.
Li YB; Wang R; Wu HL; Li YH; Zhong LJ; Yu HM; Li XJ
Oncol Rep; 2008 Sep; 20(3):549-56. PubMed ID: 18695905
[TBL] [Abstract][Full Text] [Related]
32. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells.
Xie JT; Wang CZ; Wicks S; Yin JJ; Kong J; Li J; Li YC; Yuan CS
Exp Oncol; 2006 Mar; 28(1):25-9. PubMed ID: 16614703
[TBL] [Abstract][Full Text] [Related]
33. Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro.
Yue GG; Fung KP; Tse GM; Leung PC; Lau CB
J Altern Complement Med; 2006 Oct; 12(8):777-89. PubMed ID: 17034284
[TBL] [Abstract][Full Text] [Related]
34. Ganoderma lucidum polysaccharide inhibits the proliferation of leukemic cells through apoptosis.
Zhong M; Huang J; Mao P; He C; Yuan D; Chen C; Zhang H; Hu J; Zhang J
Acta Biochim Pol; 2022 Jun; 69(3):639-645. PubMed ID: 35763830
[TBL] [Abstract][Full Text] [Related]
35. Effects of non-steroidal anti-inflammatory drug-activated gene-1 on Ganoderma lucidum polysaccharides-induced apoptosis of human prostate cancer PC-3 cells.
Wu K; Na K; Chen D; Wang Y; Pan H; Wang X
Int J Oncol; 2018 Dec; 53(6):2356-2368. PubMed ID: 30272272
[TBL] [Abstract][Full Text] [Related]
36. A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide.
Liu X; Yang L; Li G; Jiang Y; Zhang G; Ling J
Int J Biol Macromol; 2023 Feb; 229():168-180. PubMed ID: 36587634
[TBL] [Abstract][Full Text] [Related]
37. Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities.
Xu Z; Chen X; Zhong Z; Chen L; Wang Y
Am J Chin Med; 2011; 39(1):15-27. PubMed ID: 21213395
[TBL] [Abstract][Full Text] [Related]
38. Emerging Roles of
Wang J; Cao B; Zhao H; Feng J
Aging Dis; 2017 Dec; 8(6):691-707. PubMed ID: 29344411
[No Abstract] [Full Text] [Related]
39. A review of Ganoderma lucidum polysaccharides: Health benefit, structure-activity relationship, modification, and nanoparticle encapsulation.
Kou F; Ge Y; Wang W; Mei Y; Cao L; Wei X; Xiao H; Wu X
Int J Biol Macromol; 2023 Jul; 243():125199. PubMed ID: 37285888
[TBL] [Abstract][Full Text] [Related]
40. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
Kai L; Levenson AS
Anticancer Res; 2011 Oct; 31(10):3323-30. PubMed ID: 21965742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
